Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis

NCT04507659 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: Jaktinib Hydrochloride Tablets
DRUG: Jaktinib Hydrochloride Tablets
DRUG: Placebo

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd